Mesoblast Limited logo
Mesoblast Limited MESO
$ 10.9 -2.42%
report update icon

Quarterly report 2022-Q2
added 11-17-2026

Mesoblast Limited Interest Expense | MESO

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.
Includes:
  • Interest on bank loans
  • Interest on corporate bonds
  • Interest on leases
  • Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Mesoblast Limited

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
21.8 M 20.7 M 19.4 M 16.9 M 15.9 M 14.7 M 11.7 M 1.83 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
21.8 M 1.83 M 15.4 M

Quarterly Interest Expense Mesoblast Limited

2025-Q4 2025-Q2 2024-Q4 2024-Q2 2023-Q4 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
11.3 M 21.8 M 10.7 M 20.7 M 10.2 M 19.4 M 4.9 M 4.9 M 4.55 M - 4.3 M 4.06 M 4.14 M - 3.95 M 3.99 M 3.93 M - 3.73 M 3.6 M 3.58 M 2.49 M 3.14 M 2.49 M 2.65 M - 423 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
21.8 M 423 K 6.73 M

Interest Expense of other stocks in the Biotechnology industry

Issuer Interest Expense Price % 24h Market Cap Country
Amicus Therapeutics Amicus Therapeutics
FOLD
10.2 M - - $ 4.47 B usaUSA
Frequency Therapeutics Frequency Therapeutics
FREQ
5.23 M - - $ 528 M usaUSA
Galecto Galecto
GLTO
1.17 M - - $ 762 M danmarkDanmark
GlycoMimetics GlycoMimetics
GLYC
651 K - 9357.83 % $ 1.01 B usaUSA
Graybug Vision Graybug Vision
GRAY
268 K - -11.23 % $ 9.65 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
11.4 M - -32.59 % $ 7.61 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
263 K - 1.35 % $ 17.8 M chinaChina
Novavax Novavax
NVAX
40.6 M $ 7.47 -3.24 % $ 1.21 B usaUSA
Hepion Pharmaceuticals Hepion Pharmaceuticals
HEPA
9.46 K - -18.79 % $ 39.3 K usaUSA
Hoth Therapeutics Hoth Therapeutics
HOTH
27.1 K - - $ 18.8 M usaUSA
IMARA IMARA
IMRA
-49 K - 15.96 % $ 663 M usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
8.56 M - - $ 1.45 B britainBritain
KemPharm KemPharm
KMPH
1.5 M - -0.34 % $ 200 M usaUSA
Kezar Life Sciences Kezar Life Sciences
KZR
1.55 M - - $ 53.3 M usaUSA
Lixte Biotechnology Holdings Lixte Biotechnology Holdings
LIXT
9.16 K - - $ 63.4 M usaUSA
Magenta Therapeutics Magenta Therapeutics
MGTA
-974 K - -7.74 % $ 41.6 M usaUSA
NovaBay Pharmaceuticals NovaBay Pharmaceuticals
NBY
-20 K - - $ 11.3 M usaUSA
NeuroBo Pharmaceuticals NeuroBo Pharmaceuticals
NRBO
735 K - 0.43 % $ 12 M usaUSA
OncoCyte Corporation OncoCyte Corporation
OCX
1.01 M - 17.22 % $ 355 K usaUSA
Onconova Therapeutics Onconova Therapeutics
ONTX
478 K - -0.47 % $ 21 M usaUSA
Opthea Limited Opthea Limited
OPT
46.5 M - - $ 1.2 B australiaAustralia
Verastem Verastem
VSTM
1.14 M $ 6.33 -7.8 % $ 439 M usaUSA
BiomX BiomX
PHGE
-919 K $ 1.85 14.2 % $ 3.02 M israelIsrael
Pieris Pharmaceuticals Pieris Pharmaceuticals
PIRS
727 K - -15.58 % $ 1.22 B germanyGermany
Plus Therapeutics Plus Therapeutics
PSTV
395 K - - $ 301 M usaUSA
Pluristem Therapeutics Pluristem Therapeutics
PSTI
476 K - -1.9 % $ 33.3 M israelIsrael
Qualigen Therapeutics Qualigen Therapeutics
QLGN
988 K - 5.59 % $ 1.16 M usaUSA
Qilian International Holding Group Limited Qilian International Holding Group Limited
QLI
555 K - -6.08 % $ 184 M chinaChina
Cassava Sciences Cassava Sciences
SAVA
-203 K - - $ 110 M usaUSA
Selecta Biosciences Selecta Biosciences
SELB
-2.01 M - -8.69 % $ 126 M usaUSA
Sangamo Therapeutics Sangamo Therapeutics
SGMO
-3.56 M - - $ 50.4 M usaUSA
Sensei Biotherapeutics Sensei Biotherapeutics
SNSE
32 K - - $ 17.5 M usaUSA
Sonnet BioTherapeutics Holdings Sonnet BioTherapeutics Holdings
SONN
20.7 K - - $ 826 K usaUSA
Synthetic Biologics Synthetic Biologics
SYN
95 K - 1.32 % $ 16.2 M usaUSA
Synlogic Synlogic
SYBX
-2 K - - $ 7.07 M usaUSA
Virios Therapeutics, LLC Virios Therapeutics, LLC
VIRI
-6.07 M - 2710.01 % $ 72.9 M usaUSA
Vallon Pharmaceuticals Vallon Pharmaceuticals
VLON
250 K - -6.47 % $ 5.76 M usaUSA
Vaxart Vaxart
VXRT
-11 K - -25.06 % $ 46.3 M usaUSA
XOMA Corporation XOMA Corporation
XOMA
12.2 M - - $ 485 M usaUSA
Sesen Bio Sesen Bio
SESN
296 K - 7.29 % $ 127 M usaUSA
Windtree Therapeutics Windtree Therapeutics
WINT
-408 K - - $ 26.8 M usaUSA
Trean Insurance Group Trean Insurance Group
TIG
3.27 M - - $ 316 M usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
-3 K - 57.95 % $ 12.8 M usaUSA
MEI Pharma MEI Pharma
MEIP
-16 K - 10.43 % $ 20.5 M usaUSA
Palatin Technologies Palatin Technologies
PTN
290 K - - $ 13 M usaUSA